FDA Links 10 Child Deaths to COVID-19 Vaccines, Enhances Oversight Measures
The New York Times has disclosed an internal memo from the Food and Drug Administration (FDA) that suggests at least 10 children may have died "due to" COVID-19 vaccines, citing myocarditis as a possible cause.
According to the report, the memo, authored by the FDA's chief medical officer Dr. Vinay Prasad, did not provide details on the ages of the deceased children or any underlying health conditions, nor did it mention the manufacturers of the vaccines in question.
Dr. Prasad described these findings as a "profound revelation" and announced plans to enhance vaccine monitoring, including the necessity for randomized studies across all demographics.
This disclosure comes at a time when U.S. vaccination policy is undergoing significant changes, with Health Secretary Robert Kennedy Jr. modifying official recommendations to restrict vaccine access primarily to high-risk groups, including individuals aged 65 and older and those with underlying health conditions.
It is important to note that Secretary Kennedy has been a long-time vaccine skeptic prior to his appointment and is known for linking vaccines to autism and advocating for a reevaluation of national vaccination policies.
Additionally, the New York Times reported that the vaccine advisory committee of the Centers for Disease Control and Prevention (CDC) is scheduled to meet in the coming days to discuss these developments.
Dr. Vinay Prasad, an oncologist, has been a vocal critic of COVID-19 vaccine mandates and mask-wearing in the U.S. He resumed his role as chief medical officer at the FDA last September, where he advises the commissioner and senior officials on emerging medical and scientific issues.
The U.S. Department of Health and Human Services, which oversees the FDA, did not respond to a request for comment from Reuters regarding this report at the time of publication.
